Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eszopiclone for CPAP Compliance in OSA
NCT00612157Phase 4Completed
- Sponsor
- Walter Reed Army Medical Center
- Start
- Jan 2008
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in obstructive sleep apnea (OSA) comparing Eszopiclone with Placebo (2 arms). Primary endpoints: Short term CPAP Compliance at 3 months and Intermediate CPAP Compliance at 1 year. Started Jan 2008; status: completed.
02
Drugs
eszopiclone
03
Conditions
obstructive sleep apnea (OSA)
Beyond the preview
Go deeper on NCT00612157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00612157.